I'd be surprised if it was exclusive. From the same announcement
"In addition, Alchemia has a platform technology, VAST®, discovery drug discovery platform, which is
based on Alchemia’s chemistry expertise. VAST is run on a business model designed to limit use of
cash expenditure through the use of partnerships and government grants. Alchemia has projects
running with academic institutions and evaluation underway with global pharmaceutical partners.
astrazeneca multi-target drug discovery collab, page-26
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable